Skip to main content
Monday, November 16, 2026Nov 16

Deal will let more companies make overdose antidote spray

Sgt. Chris Rice stands behind the Red Bank Police Department on November 8, 2016 and speaks about his experience using Narcan nasal spray to save a man from a drug overdose on October 27 of this year. Sgt. Rice was the first officer from the department to use the spray which is now standard issue for Red Bank Police Officers.
Sgt. Chris Rice stands behind the Red Bank Police Department on November 8, 2016 and speaks about his experience using Narcan nasal spray to save a man from a drug overdose on October 27 of this year. Sgt. Rice was the first officer from the department to use the spray which is now standard issue for Red Bank Police Officers.

NEW YORK (AP) — More companies could begin making an easy-to-use version of an opioid overdose antidote under a deal announced Thursday by New York’s attorney general.

Under the agreement, Emergent BioSolutions will no longer enforce a contract that had allowed it to be the only company to sell naloxone in a spray called Narcan, a popular form for police, firefighters and others to use to try to revive people who are overdosing.

The attorney general’s office said the new agreement came after it found that Adapt Pharma, which has since been bought by Rockville, Maryland-based Emergent, had the exclusive rights to sell naloxone using Aptar Pharma’s nasal spray technology.

“Given the tragic, devastating effects of the opioid crisis, and the urgent need for additional drugs for the emergency treatment of opioid overdoses, my office will do whatever possible to ensure that there are no unnecessary impediments to the development of additional life-saving opioid overdose reversal drugs,” Attorney General Letitia James said in a written statement.

New York and most other states allow naloxone to be sold without prescriptions. But the price of Narcan — currently averaging about $140 for two doses — has been a drain on governments’ budgets and a barrier to saving some people from overdoses.